Jun 26, 2024, 02:10
Intratumoral immune triads are required for effective immunotherapy
NCI Division of Cancer Biology shared on X:
“Using preclinical models in an NCI-funded study, Gabriel Espinosa Carrasco, The SchietiLab, et al. found that intratumoral immune triads (with a dendritic cell, CD4 T cell, and CD8 T cell) are required for effective immunotherapy.”
Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors
Authors: Gabriel Espinosa-Carrasco, Edison Chiu, Aurora Scrivo, Paul Zumbo, Asim Dave, Doron Betel, Sung Wook Kang, Hee-Jin Jang, Matthew D. Hellmann, Bryan M. Burt, Hyun-Sung Lee, Andrea Schietinger
Source: NCI Division of Cancer Biology/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 18, 2024, 12:50
Nov 18, 2024, 12:20
Nov 18, 2024, 12:17
Nov 18, 2024, 12:13
Nov 18, 2024, 12:01
Nov 18, 2024, 11:56